National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Benign rolandic epilepsy (BRE)



Could you please tell me more about benign rolandic epilepsy?  I have been unable to find information about this type of epilepsy. 


What is benign rolandic epilepsy?

Benign rolandic epilepsy (BRE) is the most common form of childhood epilepsy. It is referred to as "benign" because most children outgrow the condition by puberty. This form of epilepsy is characterized by seizures involving a part of the brain called the rolandic area.[1] These seizures typically begin between the ages of 3 and 12 years and occur during the nighttime.[2] Other features of BRE include headaches or migraines and behavioral and/or learning differences.[3] BRE is thought to be a genetic disorder because most affected individuals have a family history of epilepsy.[3][4] Treatment for BRE may depend on the symptoms and severity in each person. Because BRE resolves on its own before adulthood, many children with BRE who have infrequent seizures that only occur at night do not take anti-epileptic drugs (AEDs).[1] However, there have been studies suggesting that BRE may cause lasting cognitive or behavioral problems in some people.[5] Medication is more likely to be recommended in children with frequent or daytime seizures, cognitive impairment, or a learning disorder.[1] Each family must consult with their physician(s) and make their own decision about whether to treat BRE.[3]
Last updated: 6/4/2018

What causes benign rolandic epilepsy (BRE)?

BRE is thought to be a genetic disorder. Studies suggest that certain regions on chromosome 11 (11p13) and chromosome 15 (15q14) may be involved in BRE, but a specific gene has not been identified.[4]
Last updated: 7/26/2016

What are the signs and symptoms of benign rolandic epilepsy (BRE)?

BRE typically begins between the ages of 3 and 13 years with nighttime seizures. The episodes usually begin with twitching and stiffness in the face, that often wakes up the individual.[6] There may be a tingling feeling on one side of the mouth that involves the tongue, lips, gums and inside of the cheek.[6][7] The seizure can also involve the throat, which may make speech unclear and difficult to understand.[7] Occasionally, both sides of the body may be affected, which can lead to stiffness and jerking movements of the arms and legs, and loss of consciousness. Loss of bladder control (incontinence) may also occur.[7]

Some individuals with BRE experience headaches or migraines, learning difficulties, and behavioral problems during the period of time that they have seizures. In many children, once seizures stop and brain activity returns to normal, these issues resolve.[1][5] However, there have been studies suggesting that cognitive or behavioral problems may persist in some people.[5] More studies regarding whether there is an increased chance of long-term impairments in those with BRE are needed.[8][5]
Last updated: 6/4/2018

How might benign rolandic epilepsy (BRE) be treated?

Treatment for BRE may depend on the symptoms and severity in each person. In general, BRE typically does not require intensive therapy.[3] Because seizures may be infrequent and usually occur at night, and because of the potential side affects of anti-epileptic drugs, many children with BRE do not take medication.[1][9] However, emerging data on neuropsychological problems in people with BRE suggests that the syndrome may not be entirely without long-term effects.[9] A recently recognized concern in children with BRE is a higher incidence of neuropsychological deficits.[9] Each family must consult with their physician(s) and make their own decision about whether they are more comfortable treating or not treating BRE.[3] The need for medication is generally bigger if a child has frequent seizures, daytime seizures, cognitive problems, or a learning disorder.[1]

When BRE is treated, medications may include AEDs such as carbamazepine, gabapentin, levetiracetam, or others. Most children with BRE respond to a low dose of a single drug, but some have seizures that are more drug-resistant, requiring higher doses or more than one drug.[3]
Last updated: 6/4/2018

We hope this information is helpful. We strongly recommend you discuss this information with your doctor. If you still have questions, please contact us.

Warm regards,
GARD Information Specialist

Please see our Disclaimer.


  1. Holmes GL, Fisher RS, Hernandez A. Benign Rolandic Epilepsy. Epilepsy Foundation. February 2, 2015; http://www.epilepsy.com/learn/types-epilepsy-syndromes/benign-rolandic-epilepsy.
  2. Mellish LC, Dunkley C, Ferrie CD, Pal DK. Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility. Arch Dis Child. January 2015; 100(1):62-67. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283698/.
  3. Kaddurah AK. Benign Childhood Epilepsy. Medscape Reference. December 23, 2015; https://emedicine.medscape.com/article/1181649-overview#a7.
  4. Kniffen CL, Lopez A, McKusick VA. Centralopathic Epilepsy. Online Mendelian Inheritance in Man (OMIM). September 9, 2015; http://www.omim.org/entry/117100.
  5. Camfield C, Camfield P. Cognitive Disabilities and Long-term Outcomes in Children with Epilepsy: A Tangled Tail. Send to Semin Pediatr Neurol. November, 2017; 24(4):243-250. https://www.ncbi.nlm.nih.gov/pubmed/29249504.
  6. Blumstein MD, Friedman MJ. Childhood Seizures. Emerg Med Clin N Am. November 2007; 25(4):1061-86. https://www.ncbi.nlm.nih.gov/pubmed/17950136.
  7. Appleton R. Benign rolandic epilepsy. Epilepsy Action. November 2016; http://www.epilepsy.org.uk/info/benign.html.
  8. Verrotti A, Matricardi S, Di Giacomo DL, Rapino D, Chiarelli F, Coppola G. Neuropsychological impairment in children with Rolandic epilepsy and in their siblings. Epilepsy Behav. July, 2013; 28(1):108-112. https://www.ncbi.nlm.nih.gov/pubmed/23708147.
  9. Kim H, Kim SY, Lim BC, et al. Spike persistence and normalization in benign epilepsy with centrotemporal spikes - Implications for management. Brain Dev. May, 2018; [Epub ahead of print]: